United Patients Group

FEBRUARY 8, 2023

It’s no wonder that doctors are looking for new ways to treat patients with chronic pain without resorting to these highly addictive substances. Opioids are also prescribed to treat pain and other medical conditions such as coughs, diarrhea and muscle spasms. Cannabinoids may have potential in treating chronic pain.

Chronic Pain 83

Chronic Pain Cannabinoids Research and Development Patients 83

MMJ Recs

FEBRUARY 18, 2024

As society re-evaluates its stance on cannabis, a growing body of research is uncovering the therapeutic potential of this plant. These may include chronic pain, nausea and vomiting related to chemotherapy, muscle spasms, seizures, and mental health disorders.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

United Patients Group

AUGUST 1, 2023

Alleviating Chronic Pain One of the most widely acknowledged benefits of medical cannabis is its ability to manage pain. Overall, the benefits of medical cannabis in pain management are numerous and increasingly recognized by medical professionals and patients alike.

Epilepsy 52

Epilepsy Sleep Chronic Pain Research and Development 52

Cannabis Law Report

SEPTEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, has acquired the exclusive worldwide rights from Nanomerics Ltd. Mack, Chairman and CEO of Virpax. VRP324 is manufactured using high pressure homogenization and spray drying.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

MMJ Recs

FEBRUARY 3, 2021

THC can offer medical relief from the symptoms of several ailments and conditions, including: Chronic pain Insomnia Glaucoma Loss of appetite Nausea Anxiety Autism. Recent studies have found that the use of CBD oil in cancer helped to reduce nausea, vomiting, and pain in patients undergoing chemotherapy treatments.

Cannabinoids 52

Cannabinoids Patients Blood Pressure Chronic Pain 52

United Patients Group

OCTOBER 25, 2023

To address these concerns and provide clear, evidence-based answers to the most frequently asked questions about medical marijuana, we have compiled a comprehensive FAQ to help both patients and the general public make educated decisions about their healthcare options. What Conditions Can Medical Marijuana Treat?

Marijuana 91

Marijuana Patients Research and Development Edibles 91

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS Envelta is Virpax’s endogenous enkephalin intranasal spray for acute and chronic pain, including pain associated with cancer. In October 2021, Virpax announced that a $1.87

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

MGC Pharma

FEBRUARY 15, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. Physicians who want to prescribe Medicinal Cannabis are required to jump through countless regulatory hoops, as are patients seeking treatment.

Access 100

Access Medicine Chronic Pain Research and Development 100

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. It is a synthetic form of THC, the active ingredient found in marijuana. 5, or 10 milligrams of THC.

THC 98

THC Chronic Pain Treatment Conditions 98

United Patients Group

FEBRUARY 2, 2023

The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). Cannabis has been shown in several studies to improve the quality of sleep and reduce daytime drowsiness for people who suffer from chronic pain.

Blood Pressure 104

Blood Pressure Sleep Chronic Pain Digestion 104

United Patients Group

APRIL 18, 2023

However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. For example, if you have chronic pain and want relief from muscle spasms and stiffness in your joints, then an indica strain may be best for you. Myth: Cannabis is just a drug.

Research and Development 110

Research and Development Indica Treatment Conditions 110

The Herb Collective

AUGUST 1, 2023

Pain Reduction: Cannabis Indica is a natural choice for individuals enduring chronic pain. Its ability to aid in pain reduction has attracted patients and doctors alike, who appreciate the chemical compounds found in the plant that work to reduce inflammation.

Indica 87

Indica Blood Pressure Epilepsy Sleep 87

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Doctors prescribe various forms of opiods to cancer patients for pain.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Veriheal

MAY 31, 2022

With a worsening opioid situation and an emerging acceptance of medical cannabis, the Lone Star State has a unique opportunity to develop a successful medical marijuana (MMJ) program for its millions of residents battling chronic pain and numerous other conditions. A 2019 study found that 76% of patients in the U.S.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

SEPTEMBER 6, 2021

For instance, it is very effective in reducing nausea and increasing appetite among chemotherapy patients. Similarly, it is also used in combination with traditional opioid painkillers, which enables patients to reduce the dosage and frequency of opioids significantly and imparts greater pain relief. Chronic Pain.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Doctors prescribe various forms of opiods to cancer patients for pain.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

MMJ Recs

FEBRUARY 3, 2024

In recent years, the landscape of medical marijuana laws has evolved, presenting new opportunities and challenges for patients, healthcare providers, and industry stakeholders. Understanding these regulations is crucial for patients, caregivers, and dispensaries alike to ensure compliance with the law.

Legislation 52

Legislation Law Marijuana Dispensary 52

FloridaMarijuana.net

OCTOBER 18, 2018

A 2006 edition of Current Pharmacology published an article titled: “Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes”. Once medical marijuana is ingested, the receptors are opened and the medication begins to provide relief to patients.

Cannabinoids 169

Cannabinoids THC Chronic Pain Patients 169

Cannabis Law Report

NOVEMBER 24, 2019

Recommendations for research. Chronic pain. Severe treatment-resistant epilepsy. Chronic pain. Do not offer the following to manage chronic pain in adults: nabilone. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. Recommendations. Spasticity.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. ” A study conducted by The G4 Alliance reports 300 million surgical procedures are performed annually, with an estimated 60 to 70% of patients experiencing moderate to severe pain just after 24 hours of surgery.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

CannaTech

JUNE 30, 2019

Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Severe epilepsy in minors.

Patients 40

Patients Oil Epilepsy Strains 40

MMJ Recs

DECEMBER 22, 2023

Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance. Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

CannaTech

JUNE 30, 2019

These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. The main goal of the reform is to ease bureaucratic hurdles for patients and to improve the quality and consistency of medical cannabis. Severe epilepsy in minors.

Patients 90

Patients Oil Epilepsy Strains 90

Veriheal

MAY 24, 2023

This leaves millions of medical cannabis patients unable to consume their legal marijuana doses until they get home. In fact, medical cannabis experts prescribe marijuana inhalation (over other dosage methods) for severe conditions like epilepsy , chronic pain , and insomnia.

Consumption 84

Consumption Vaping Chronic Pain Recreational 84

United Patients Group

APRIL 24, 2023

In addition, cannabis might also help improve heart health by reducing inflammation around vessels; this reduces the risk of developing atherosclerosis (the hardening of arteries) or plaque buildup inside them. In addition to these potential side effects, some epilepsy medications have been linked with depression and suicidal thoughts.

Blood Pressure 52

Blood Pressure Sleep Cannabinoids Research and Development 52

Cannabis Law Report

DECEMBER 28, 2021

These accomplishments include accelerated development of our existing product candidates, broadening our pipeline of product candidates, and utilizing grants where appropriate. Nanomerics’) has enabled the development of product candidates for central nervous system (‘CNS’) and anti-viral indications. Mack, Chairman and CEO of Virpax.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

JANUARY 27, 2022

Assembly Bill 8569 would legalize psilocybin services only for medical purposes and require that a patient is “certified” before receiving treatment. Practitioners would need a new psilocybin-license before they could certify patients for treatment. However, one possible pro of New York’s medical approach is the focus on research.

Legalization 52

Legalization Research and Development Legislation Treatment 52

The Cannigma

FEBRUARY 21, 2021

They are making those moves,” said Jake Kuczeruk, vice president of business development at The Arcview Group, a cannabis investment, consulting, and research group. If the cultivators could develop a relationship with their customers, they could get a lot more brand loyalty,” Dr. Fisher explained. billion by 2024.

Research and Development 118

Research and Development Pharmaceutical Recreational Cannabis 118

Cannabis Law Report

MARCH 6, 2020

“Kannalife’s research has the potential to make a global impact as their growing portfolio of international patents pushes forward their go-to-market strategy.” KLS-13019 has not been reviewed or approved for patient use by the U.S. It’s safety and efficacy have not been confirmed by FDA-approved research.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

Cannabis Law Report

NOVEMBER 10, 2021

Additionally, when a diabetes drug interferes with CBD, it may cause diarrhea in a patient. But, if you have a medical condition, such as heart issues, kidney disease, epilepsy, or a weakened immune system due to cancer, avoid taking CBD oil without a doctor’s consultation. May Cause Injury To The Liver. Bottom Line.

Oil 52

Oil CBD Research and Development Chronic Pain 52

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Alchimia

FEBRUARY 1, 2022

Recent scientific studies have proven that cannabidiol contains the following therapeutic properties: Anticonvulsant : especially suitable to treat Dravet syndrome, a very aggressive type of childhood epilepsy. Neuroprotective : could contribute to the treatment of neurodegenerative diseases such as multiple sclerosis. Drowsiness.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52